Adaptive Biotechnologies (ADPT) Misses Q3 EPS by 1c

Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $37.92 million versus the consensus estimate of $42.96 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Navios Maritime Partners (NMM) Tops Q2 EPS by 34c
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings